Are Alzheimer’s blood tests ready for primetime?
In The Conversation, Drs. Steven DeKosky and Todd Golde discuss the progress and challenges of Alzheimer’s diagnostics.
In The Conversation, Drs. Steven DeKosky and Todd Golde discuss the progress and challenges of Alzheimer’s diagnostics.
In the Conversation, Dr. Steven DeKosky weighs in on a new report discouraging the use of dietary supplements to prevent cognitive decline, dementia or Alzheimer's.
Seven McKnight Brain Institute members from four colleges were named UF Research Foundation Professors for 2019-2022.
Expert neuroscientists who study age-related memory loss at all four McKnight Brain Institutes in the U.S. came together in Gainesville for 11th annual meeting.
In the journal Neuron, Dr. Golde highlights the promise and challenges of a possible path to treat Alzheimer’s disease and other neurodegenerative disorders.
Three renowned neuroscientists from top U.S. research institutions — Drs. Malú G. Tansey, Ph.D., Matthew LaVoie, Ph.D., and Stefan Prokop, M.D. — will join the newly established Norman Fixel Institute for Neurological Diseases at UF Health.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.